About Kume Clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
9
Pfizer
5
LEO Pharma
1
Clinical Trials at Kume Clinic
During the past decade, Kume Clinic conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on
average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 11 clinical trials were completed. i.e. 275%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)
2017-05-30
2019-10-10
Completed
802
A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
2017-11-23
2019-08-16
Completed
660
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
2018-03-28
2023-08-07
Active, not recruiting
1,645
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable
2018-05-15
2023-05-02
Active, not recruiting
463
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
2018-04-24
2020-01-16
Completed
530
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
2018-09-03
2022-02-07
Terminated
1,936
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
2018-06-29
2019-08-13
Completed
391
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2018-10-29
2020-03-06
Completed
838
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kume Clinic"
#1 collaborator was "Incyte Corporation" with 4 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Kume Clinic
According to Clinical.Site data, the most researched conditions in "Kume Clinic" are
"Atopic Dermatitis" (10 trials), "Dermatitis, Atopic" (3 trials), "Eczema" (3 trials), "Dermatitis" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Kume Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Kume Clinic
Most popular intervention types in "Kume Clinic" are "Drug" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Baricitinib" (4 trials), "Topical corticosteroid" (3 trials), "Lebrikizumab" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kume Clinic
The vast majority of trials in "Kume Clinic" are
15 trials for "All" genders.
Clinical Trials Status at Kume Clinic
Currently, there are NaN active trials in "Kume Clinic".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Kume Clinic,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Kume Clinic, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".